Table 4 Response of angiomyolipoma volume to everolimus by genotype

AML volume at baseline (mean ± SD, cm³)

70 ± 76

235 ± 538

0.54

Age range (years)

29–45

16–59

0.079

 Median age (years)

36

34

Sex

0.63

 Male

2

25

 Female

2

43

Familial/de novo

0.17

 Familial

2

12

 De novo

2

56

Everolimus (3 months)

 No. of response (%)

3 (75)

52 (76)

0.99

 % reduction from baseline value (mean ± SD, %)

39 ± 14

38 ± 17

0.89

Everolimus (6 months)

 No. of response (%)

4 (100)

56 (85)

0.99

 % reduction from baseline value (mean ± SD, %)

41 ± 15

43 ± 18

0.87